2020 State of the Art of Psychedelic Technology – Where Is It Heading?
In 2020, the path forward for psychedelic drug research goes in several directions.
Articles by Barbara E. Bauer, MS
Is Ibogaine a Psychedelic Drug?
Yes, based on its effects. But it doesn’t work via the serotonin 5-HT2A receptor like other psychedelics.
Scientists Synthesize and Test the Magic Mushroom Compounds Baeocystin, Norbaeocystin, Norpsilocin, and Aeruginascin
This work is a giant step forward for psychedelic research.
The Miller School of Medicine is Studying CBD + Psilocybin for Treating Traumatic Brain Injury and PTSD
The University of Miami medical school study is funded by a $1.624 million grant from Tassili Life Sciences.
The Structure and Function of the Serotonin 5-HT1A Receptor
Activation of neuronal 5-HT1A receptors causes hyperpolarization and inhibition of cellular signaling.
Washington, DC Moves to Decriminalize Naturally Occurring Psychedelics
Decriminalize Nature DC is driving the effort to get the initiative on the November ballot.
The Structure-Activity Relationship of Two Kratom Compounds
Even slightly modifying the chemical structure of the compounds in kratom can significantly alter their effects.
Is Kratom a Psychedelic Drug?
Technically the answer is no, but subjective experiences may vary.
Positive Effects of Single-Dose Psilocybin Last Nearly 5 Years
After 4.5 years, 60-80% of the study participants with life-threatening cancer still experienced significantly decreased anxiety or antidepressant effects.
The Structure and Function of the Serotonin 5-HT2A Receptor
The 5-HT2A receptor is central to the effects of many psychedelics, but it may not be the only receptor involved.